Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
The miRNA-4330/ABCG2 axis overcomes drug resistance and cancer progression in both ER-positive and ER-negative resistant breast cancer cells.
Shaymaa M M Yahya, Sohair M Salem, Heba K Nabih, Shimaa Ibrahim Abdelmenym Mohamed, Ghada H Elsayed
Published: 202610.1007/s12094-025-04138-y
Abstract
BACKGROUND: This study sought to uncover novel targets for fighting drug resistance in breast cancer therapy, such as miRNA that target ABC transporters and decrease the oncogenic activity of breast cancer cells. METHODS: MiRNA ABC transporter target…
Preview only. Read the full abstract at the source